Skip to content

Pharming Group N.V.

PHAR· NasdaqCore metricsCIK 1828316

Pharmaceutical preparations552 peers

Last sale
Nov 9, 2026 · +7.09%
Market cap
$922.01M
70.17M shares
Filings
149
$376.13M
FY 2025+26.6% FY25 yoy
$2.85M
FY 2025N/M FY25 yoy
$25.84M
FY 2025N/M FY25 yoy
$53.96M
FY 2025derivedN/M FY25 yoy
$0.00
FY 2025N/M FY25 yoy
$145.31M
FY 2025+164.5% FY25 yoy
$922.01M
323.4×
2.5×
3.3×
5.85%
—

FY2025 figures · derived

Price

$13.1423.43%$4.02past year
Nov 9, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$376.13MFY 2025
$376.13M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$376,134,000reported
FY 20242024-12-31$297,200,000reported
FY 20232023-12-31$245,316,000reported
FY 20222022-12-31$205,622,000reported
FY 20212021-12-31$198,871,000reported
FY 20202020-12-31$212,174,000reported
FY 20192019-12-31$189,389,000reported

Segments

Operating income by Geography, FY2020 to FY2022FY2020FY2021FY2022
LineFY2022ShareChange
U.S.-$670.00K—N/M
NETHERLANDS-$13.56M—N/M
France———
Total$18.23M

From the 20-F filed Apr 5, 2023PHAR

Pharmaceutical preparations

Pharming Group N.V. is the 63rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Pharming Group N.V. · CIK 1828316 · Engraved from SEC EDGAR